Adhera Therapeutics, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets
Adhera Therapeutics, Inc. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets of $2.36 million as of 2017-12-31, per its 10-K filed 2018-04-17.
Discontinued › Notes › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill, Less Noncontrolling Interest › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets · last filed 2018-04-17
- 2017-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets $2.36M.
- 2017-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets $2.36M.
- 2017-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets $2.36M.
- 2017-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets $2.36M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets |
|---|---|
| 2017-12-31 | $2.36M 10-K · filed 2018-04-17 |
| 2017-09-30 | $2.36M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $2.36M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $2.36M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $2.36M 10-K · filed 2017-03-31 |